Sequencing the New Horizon in Clinical Molecular Diagnostics

Non-infectious disease molecular assays represent approximately only 1% of the global in vitro diagnostics (IVD) market, but are recognized by nearly every significant industry player as the most promising diagnostics area in terms of market development and future growth. IVD-leading growth in molecular diagnostics is fueled by genomic discovery and gradually improving coverage under health insurance. Not since the commercialization of polymerase chain reaction (PCR) tests has molecular diagnostics been presented with such a promising technology as next-generation sequencing (NGS).

Ionizing Tea Leaves – Kalorama Explores the Future of Clinical Mass Spectometry

The sophistication and analytical flexibility of mass spectrometry systems traditionally excluded them from routine clinical diagnostics. Today, mass spectrometry and its derivative technologies – gas chromatography mass spectrometry (GC-MS), liquid chromatography mass spectrometry (LC-MS), liquid chromatography tandem mass spectrometry (LC-MS/MS), and others – are seeing increasingly wider usage in healthcare. Led by the rising application of MALDI-TOF and tandem mass spectrometry, the global clinical mass spectrometry market is projected to grow by roughly 9-10% annually in the coming years.

The Hungry Dragon – China in the Global Clinical Nutrition Market

China has yet to claim first or second billing in most major clinical or healthcare product markets, despite its exceptional economic growth, heavy public-private mix in healthcare investment, and its roughly 1.4 billion residents. China’s potential is already evident in clinical nutrition with Kalorama Information estimating it to be the second largest national market.

Veterinary Diagnostics - Epidemiological Update

In Kalorama Information’s last edition of its veterinary diagnostics market study, bovine viral diarrhea (BVD) was estimated to be among the largest food animal infectious disease test markets in the world. Once rivaling transmissible spongiform encephalopathies (TSEs) in terms of global test market size, BVD is giving way to emergent disease threats that have severely impacted swine production worldwide.

IVD Market $54 Billion: Kalorama's 9th Edition Report

 The world market for diagnostics is estimated at $54.6 billion in 2013, according to Kalorama Information.   Kalorama revealed the market estimate in its biennial survey of the IVD industry, The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition.   Aside this article is a Wordle of the entire text of the report, which provides some indication of the topics that are most often discussed in its pages.   The survey can be obtained at http://www.kaloramainformati


Subscribe to Kalorama Information Home RSS